UNSPSC 51284708: Distamycin a or stallimycin

This classification denotes a distamycin antibiotic and dna minor groove binding agent with the molecular formula C22H27N9O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80O63P88IS, chemically known as distamycin a, hydrochloride but generally known as distamycin a, which bears US NIH Compound Identifier 3115. European Medicines Agency schedules Stallimycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10640MIG. The term DISTAMYCIN A is an International Non-Proprietary Name.

Distamycin a or stallimycin bears US NLM identifiers UMLS ID C0244119 and NCI Concept Code C1517. SMILES: O=C(NC1CC(N(C1)C)C(=O)NCCC(=N)N)C1N(CC(NC(=O)C2N(CC(NC=O)C2)C)C1)C.

UNSPSC 51284708 Distamycin a or stallimycin is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The four opportunities posted under this code between January and July 2026 — naloxone procurement, pharmacy benefit program direct-to-manufacturer prescriptions, medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals through cooperative purchasing — reflect actual state and local buying of pharmaceutical products, OTC supplies, and medical consumables, but diverge substantially from the antibiotic compounds the code nominally describes. State and local issuers appear to tag broad pharmaceutical and medical supply acquisitions under this code without precision targeting the specific substances named in the taxonomy.

The issuing bodies span state health agencies, counties, cities, and cooperative purchasing alliances. The Texas Health and Human Services Commission issued an RFI in April 2026 to explore direct-to-manufacturer prescription programs; Seminole County, Florida released an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (response deadline July 26, 2023); the City of Tampa posted an IFB in March 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a 5 percent SLBE bid discount (response deadline March 13, 2026); and the Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products across Minnesota, Oregon, and participating jurisdictions, with proposals due March 26, 2026. The code shows activity in Florida, Texas, and Minnesota, with procurement spanning health departments, emergency services, and state cooperative purchasing vehicles.